These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Lantabetulic acid derivatives induce G1 arrest and apoptosis in human prostate cancer cells.
    Author: Lin KW, Lin ZY, Huang AM, Weng JR, Yen MH, Yang SC, Lin CN.
    Journal: Arch Pharm (Weinheim); 2014 Jan; 347(1):42-53. PubMed ID: 24243582.
    Abstract:
    Ten new lantabetulic acid (1) derivatives 2-11 were synthesized and their cytotoxicities against human prostate cancer cells were evaluated. PC3 cells treated with 10 μM 8 exhibited the most potent G1 phase arrest. In addition, 10 μM 8 markedly decreased the levels of cyclin E and cdk2 and caused an increase in the p21 and p27 levels, while 20 μM 8 mainly led to cell death through the apoptotic pathway, which correlated with an increase in reactive oxygen species levels, decreased expression levels of Bcl-2 and caspase-8, the induction of mitochondrial changes, and decreased levels of cytochrome c in mitochondria. The dual action of 8 could provide a new approach for the development of chemotherapeutic drugs.
    [Abstract] [Full Text] [Related] [New Search]